Abivax SA (ABVX)
83.83
+1.73
(+2.11%)
USD |
NASDAQ |
Nov 18, 16:00
84.00
+0.17
(+0.20%)
After-Hours: 20:00
Abivax Debt to Equity Ratio : 0.0033 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0033 |
| March 31, 2026 | 0.0796 |
| December 31, 2025 | 0.0705 |
| Date | Value |
|---|---|
| September 30, 2025 | 0.1447 |
| June 30, 2025 | -1.752 |
| March 31, 2025 | -14.04 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 0.4699 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 0.0148 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 528.44M |
| Total Liabilities (Quarterly) | 109.69M |
| Shareholders Equity (Quarterly) | 418.75M |
| Current Ratio | 5.965 |
| Net Debt Paydown Yield | 0.19% |